The advertisement promotes Repatha (evolocumab) for patients with established cardiovascular disease (CVD), highlighting its use for individuals who have had a recent cardiovascular event and may have additional risk factors. It includes important safety information regarding contraindications and hypersensitivity reactions.
Creative Information
| CID: | 3e1afb62-f611-446e-b44a-eb940cc2b28d |
| CRID: | 89_188137 |
| Domain: | repatha.com |
| Seat: | DInt |
| Size: | 300x250 |
| Bid: | $1.50 |
| Timestamp: | 11/17/2025, 5:57:05 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/17/2025, 6:32:39 PM | 7.65s | |
| adomain_analysis | success | 11/17/2025, 7:57:52 PM | 3.43s | |
| adomain_capture | success | 11/17/2025, 7:57:48 PM | 0.20s | |
| ad_render | success | 11/17/2025, 6:32:32 PM | 34.09s | |
| brand_mapping | success | 11/17/2025, 5:57:05 PM | 0.11s | |
Analysis Results
Ad Format: banner
Brands: Repatha
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1870.99 KB | ||||||||||||||||||||||
| Render Time: | 9.46 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1871.08 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


